Private Equity Firm

Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2019.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2
    August 10, 2022
    PolyPid to receive millions for commercialization of infection-fighting drug
    August 4, 2022
    Alpha Tau to do trials of cancer treatment in Korea
    August 3, 2022
    Priority Review of Gamida’s Novel Transplant Therapy Reflects Urgency, Effi
    August 1, 2022
    Washington is one of first states to license promising new cancer treatment
    July 30, 2022
    How Wasted Food Could Save the Planet
    July 27, 2022
    DiaSorin Receives FDA 510(K) Clearance for Its LIAISON® MeMed BV® Test the
    July 22, 2022
    Here Are The Startups Eyeing Solutions For High Housing Costs
    July 21, 2022
    Global Telecom Operators Move to Make Mobile Networks More Sustainable, Energ
    July 7, 2022
    PolyPid Announces Dikla Czaczkes Akselbrad Assumes Role of CEO
    July 5, 2022